mpn updates: trial updates, combinations & novel therapies
Published 4 years ago • 75 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:28
updates in mpns from asco 2024: combination therapies, trial endpoints & future directions
-
1:22
the future of mpn treatment: moving towards combination therapies
-
13:31
key highlights in mpns: novel agents, combinations, and the potential role of immunotherapy
-
11:42
thalassemia highlights at ash 2023: novel therapies, trial updates & the value of precision medicine
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
9:25
mgus diagnosis: a step-by-step approach
-
2:06
how the mpn field has evolved over the years: novel agents, trials, and more
-
2:38
mpn updates: personalized prognostication, novel treatments & more
-
2:01
impact of comorbidities on patient selection for combination therapies in cll
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
1:31
novel treatment agents and how they're changing the mpn field
-
3:22
the latest clinical trials in the treatment of mpns
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:50
novel treatment regimens under investigation for richter's transformation
-
1:43
the changing treatment landscape of pnh: novel agents and combinations
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
6:00
covid-19 and mpn updates
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml